No Location

It looks as though you are using Microsoft Internet Explorer which is no longer supported. To experience this site in the way it was designed, please upgrade to Microsoft Edge

Long-Covid: What will be the legacy from the pandemic?

Long-Covid: What will be the legacy from the pandemic?

Overview

Public lecture by Professor Chris Brightling

  • Thursday 13th May 2021 17:30
  • Event
  • Learn

Taking Part

This opportunity has already taken place

Public lectures at Newcastle University are free and open to all.

The Covid-19 pandemic has affected all our lives. As the world picks itself up with implementation of vaccines and new treatments, many will have lost loved ones, and some will still be suffering from the consequence of Covid-19. What is Long-Covid? Is it important and will this leave an indelible mark of the pandemic for years to come?

Biography:

Professor Chris Brightling’s research focusses on improving the clinical management and understanding the mechanisms of airway diseases such as asthma, chronic coughs and COPD. He has published almost 400 peer reviewed articles and is a National Institute for Health Research (NIHR) Senior Investigator, alongside many other key positions he holds within leading global respiratory disease research bodies. Professor Brightling coordinates EMBER, the UK’s Medical Research Council’s Molecular Pathology Node and is the respiratory lead for the IMI 3TR – the prestigious European Innovative Medicines Initiative consortia.

Live Q&A:

The lecture will be followed by a live Q&A with the speaker. You can submit a question in advance by sending an email to [email protected] or during the event using YouTube Live Chat or via Twitter @InsightsNCL.

This event will be hosted on YouTube, registration is not required.

Click here to watch the live stream on Thursday 13th May, 17:30. 

Newcastle University

Taking Part

This opportunity has already taken place

Long-Covid: What will be the legacy from the pandemic? Discussion

Login / Register to take part in this discussion.

Loading...